Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency Rate”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01227707
What this trial is testing

Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)Study completedNCT01915602
What this trial is testing

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

Who this might be right for
Carcinoma, Hepatocellular
Bayer 14
Large-scale testing (Phase 3)Active Not RecruitingNCT04370054
What this trial is testing

Study to Evaluate the Efficacy and Safety of PF-07055480 / Giroctocogene Fitelparvovec Gene Therapy in Moderately Severe to Severe Hemophilia A Adults

Who this might be right for
Hemophilia A
Pfizer 77
Not applicableUnknownNCT04249297
What this trial is testing

Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines

Who this might be right for
Infertility
Abbott 1,150
Testing effectiveness (Phase 2)Study completedNCT00625820
What this trial is testing

Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and Albuminuria

Who this might be right for
Kidney DiseaseAlbuminuria
University of Michigan 17
Testing effectiveness (Phase 2)Looking for participantsNCT07190300
What this trial is testing

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Who this might be right for
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Novartis Pharmaceuticals 181
Not applicableLooking for participantsNCT06477991
What this trial is testing

The Efficacy of Watch and Wait Strategy or Surgery After Neoadjuvant Immunotherapy for Locally Advanced Colorectal Cancer With dMMR/MSI-H Guided by MRD Dynamic Monitoring: A Single-center, Open-label, Prospective, Phase II Clinical Trial.

Who this might be right for
Clinical Complete Response Rate With Negative MRD
Yunnan Cancer Hospital 22
Testing effectiveness (Phase 2)Study completedNCT00387270
What this trial is testing

Safety Study of the Novel Drug Dimebon to Treat Patients With Huntington's Disease

Who this might be right for
Huntington's Disease
Medivation, Inc. 9
Large-scale testing (Phase 3)Active Not RecruitingNCT03861273
What this trial is testing

Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 51
Not applicableStudy completedNCT05758402
What this trial is testing

A Randomized, Open, Parallel, Controlled, Multi-center, Interventional, Cross-sectional Study to Evaluate the Detection Rate of Psoriatic Arthritis in Korean Moderate-to-severe Psoriasis Patients, With or Without Active Screening for Arthritis in Psoriasis (ASAP Study)

Who this might be right for
Psoriasis
Novartis Pharmaceuticals 368
Large-scale testing (Phase 3)Ended earlyNCT02174445
What this trial is testing

An Open-label, Randomised Multicenter Phase 3b Study to Determine the Confirmed Rate of Molecular Response ≥ 4 Log (MR4) at Two Years

Who this might be right for
Chronic Myeloid Leukemia
Prof. Dr. Nikolas von Bubnoff 14
Testing effectiveness (Phase 2)UnknownNCT00807261
What this trial is testing

Weekly Docetaxel and Fixed-Dose Rate Gemcitabine Combination Chemotherapy

Who this might be right for
Sarcoma
Asan Medical Center 30
Testing effectiveness (Phase 2)Study completedNCT00700570
What this trial is testing

Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 45
Early research (Phase 1)Study completedNCT03662191
What this trial is testing

Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)

Who this might be right for
Healthy Volunteers
Pfizer 9
Large-scale testing (Phase 3)Study completedNCT03566017
What this trial is testing

Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease

Who this might be right for
Fabry Disease
Chiesi Farmaceutici S.p.A. 97
Not applicableUnknownNCT04418804
What this trial is testing

Diagnosis and Classification of Pleural Diseases Using Ultrasound Channel Data

Who this might be right for
PneumothoraxPleural Effusion
Israel Aharoni 90
Post-approval studies (Phase 4)Study completedNCT00498368
What this trial is testing

Rituximab in Progressive Immunoglobulin A (IgA) Nephropathy

Who this might be right for
IgA Nephropathy
Mayo Clinic 34
Post-approval studies (Phase 4)UnknownNCT03253250
What this trial is testing

The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection

Who this might be right for
Chronic Hepatitis bHepatic Carcinoma
Huashan Hospital 432
Not applicableWithdrawnNCT03669692
What this trial is testing

Open Randomized Clinical Trial to Evaluate the Effects of Intermittent Caloric Restriction in Patients With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.

Who this might be right for
Prostatic Hyperplasia, BenignMetabolic Syndrome
Complexo Hospitalario Universitario de A Coruña
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation